Spotlight: Novartis’ Kisqali Shows Promising Results in Metastatic Breast Cancer
On December 9th, Novartis announced encouraging updates from its Phase III clinical trial, MONALEESA-7, at the San Antonio breast cancer virtual symposium. The trial demonstrated that the CDK4/6 inhibitor Kisqali …
Read More